Introduction: Treatments in NETs have been studied for effects on tumour progression and carcinoid syndrome with minimal evidence on gastrointestinal(GI) symptom burden and impact on quality of life(QoL)
Aim(s): To determine whether patients with NETs receiving treatment experience GI symptoms, and to explore their impact on QoL
Materials and methods: A prospective cohort of 46 patients with histologically confirmed NET visiting endocrine and oncology clinics completed GSRS(gastrointestinal symptom rating scale) and EORTC QLQ-GINET21 QoL questionnaires prior to establishment of a gastroenterology NET service
Conference: 13th Annual ENETS conference 2016 (2016)
Category: ...none of the above
Presenting Author: Dr Mohid Khan
To read results and conclusion, please login ...
Further abstracts you may be interested in